Factors for effective colorectal cancer screening
Abstract
Background: There is a growing emphasis on colorectal cancer (CRC) screening in global world population and also in our country. Althout there is a growing awareness of digestive cancers among the general population in Slovenia, there will remain a large proportion of the population who will not seek screening and will only be screened for CRC if their physician raises the issue or if a population based screening program is established. Despite that the CRC screening is widely recommended. There is often under-utilisation of its guidelines and certain groups are at increased risk of not receiving CRC screening or recommendations for screening in their social community. Social and health policy interventions to reduce these disparities should be an integral part of overall effort to improve CRC prevention and control in general population. CRC is unique in that there are several potential screening modalities availaible with different levels of scientific evidence to support their efficacy.
Conclusions: The purpose of CRC screening is to detect early stages of the disease with better prognosis and low mortality. Screening needs to be associated with public information programs and should provide warnings about awareness and poor incorporation of screening guidelines into primary care programs. Screening test needs to be simple, safe and acceptable. The screening tests for CRC include fecal occult blood testing (FOBT), imaging procedures which include sigmoidoscopy, colonoscopy and radiography with barium enema. Insurance coverage and health care programs are often been associated with the level of realisations of screening programs.
Downloads
References
Rak debelega črevesa in danke. Odkrijmo ga čimprej! Skrb zase. Viva 2006; 3: 1–16.
Hawley ST, Vernon SW, Levin B, Vallejo B. Prevalence of colorectal cancer screening in a large medical organisation. Cancer Epidemiol Biomarkers Prev 2004; 13: 314–19.
Gennarelli M, Jandorf L, Cromwell C, Valdimarsdottir H, Redd W, Itzkowitz S. Barriers to colorectal cancer screening: Inadequate knowledge by physicians. The mount sinai journal of medicine 2005; 72: 36–43.
Ransohoff DF, Sandler RS. Screening for colorectal cancer. N Engl J Med 2002; 346: 40–4.
Peterson SK, Vernon SW, A review of patient and physician adherence to colorectal cancer screening guidelines. Sem Colon Rect Surg 2000; 11: 58–72.
Scheifeld GS, Gemson D, Ashford A. Cancer education among primary care physicians in an underserved community. Am J Prev Med 2000; 19: 53–8.
Barrison AF, Smith C, Oviedo J. Colorectal cancer screening and familial risk: a survey of internal medicine residents knowledge and practice patterns. Am J Gastroenterol 2003; 98: 1410–16.
Hilsden RJ, MsGregor E, Murray A, Khoja S, Bryant H. Colorectal cancer screening: practice and attitudes of gastroenterologist, internists and surgeons. J Can Chir 2005; 48: 434–40.
Advisory Committee on cancer prevention. Recommendations on cancer screening in the European Union. Eur J Cancer 2000; 36: 1473–78.
Steele R, Parker R, Patnick J, Warner J, Fraser C, Mowat NA, et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of health care strategies. J Med Screen 2001; 8: 197–203.
Bretthauer M, Gondal G, larsen IK, Carlsen E, Eide TJ, Grotomol T, et al. Design, organisation and management of a controlled population screening study for detection of colorectal neiplasia. Attendance rates in the NORC-CAP study. Scand J Gastroenterol 2002; 37: 568–73.
Santavirta J. Screening sigmoidoscopy in persons aged 60 years. Colorectal Dis 2002; 4: 184–8.
Ministeril Della Sanita. Linee guida elaborate della Commissione Oncologica Nazionale, in applicazione di quanto previsto dal Piano sanitario nazionale per il triennio 1994–1996, relativo allazione programmata »Prevezione e cura delle malattie oncologiche,« concernenti l’organizzazione della prevenzione e dell’assistenza in oncologia. Gazzetta Ufficiale Della republica Italiana. Supplemento Ordinario Alla GU, No. 127. 1. Giugno 1996.
Anderson WF, Guyton KZ, Hiatt RA, Vernon SW, Levin B, Hawk E. Colorectal cancer screening for person at avarage risk. J Natl cancer Inst 2002; 94: 1126–33.
Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to Hemoccult-II in screening for colorectal cancer. A randomized study. Scand I Gastroenterol 1999; 34: 73–8.
Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A. Randomized trial of different screening strategies for colorectal cancer: patients response and detection rates. J Nat Can Inst 2005; 97: 347–57.
Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the district of Florence experience. Int J Cancer 2001; 92: 151–14.
Žerdin M, Koželj M, Skok P. Rak debelega črevesa in danke – preprečevanje in presejanje. Zdrav Vestn 2006; 75: 29–37.
Lesničar H, Pompe-Kirn V, Zakotnik B, Čufer T, Repše S, PrimicŽakelj M, et al. Preživetje bolnikov z rakom. Je po evropskih kazalcih Slovenija res padla na izpitu iz onkologije? Poročilo posveta o preživetju bolnikov z rakom v Sloveniji. Onkologija 2003; 7: 63–76.
Markovič S, Repše S, Heijnen S. Obvladovanje kolorektalnega raka. Nacionalna klinična smernica. Projekt razvoja sistema upravljanja zdravstvenega varstva. Ljubljana: Ministrstvo za zdravje; 2002.
Crespi M, Stigliano V, Assisi D. Current trends in screening and secondary prevention of colorectal cancer. Hepatogastroenterology 2001; 48: 1635–40.
Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004; 54: 41–52.
Walsh JM, Posner SF, Perez-Stable EJ. Colon cancer screening in the ambulatory setting. Prev Med 2002; 35: 209–18.
Ruffin MT, Gorenfo D, Woodman B. Predictors of screening for breast, cervical, colorectal and prostatic cancer among community-based practices. J Am Board Pract 2000; 13; 1–10.
Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med 2002; 162: 2581–6.
Ko CW, Kreuter W, Baldwin LM. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterology. Dostopno na: http://creativecommons.org/licenses/by/2.0
Dajčman D. Prvi kongres slovenskega združenja za gastroenterologijo in hepatologijo. Isis 2005; 14: 104–6.
Gadžijev EM, Markovič S, Orel J, Pegan V, Repše S, Štabuc B, et al. Priporočila za celostno obravnavo bolnikov z rakom prebavil. Ljubljana: Ministrstvo za zdravje R Slovenije; 1997.
Niv Y, Lev-El M, Fraser G, Tamir A. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 2002; 50: 33–7.
Simon JB, Fletcher RH. Should all people over the age of 50 have regular fecal occult blood tests? N Engl J Med 1998; 338: 1151–3.
Blalock SJ, DeVellis BM, Sandler RS. Participation in fecal occult blood screening: a critical review. Prev Med 1987; 16: 9–18.
Myers RE, Ross EA, Wolf TA. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 1991; 29: 1039–50.
Winawer SJ, Fletcher RH, Miller L. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 112: 594–42.
Hakama M, Hoff G, Kronborg O, Pahlman L. Screening for colorectal cancer. Acta Oncol 2005; 44: 425–39.
Results of the first round of a demonstration pilot of screening for colorectal cancer in the united Kingdom. BMJ 2004; 329: 133.
Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occul blood screening on mortality from colorectal cancer. Results from randomised controlled trial. Gut 2000; 50; 840–4.
Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing. Results after 13 years and seven biennal screening rounds. Gut 2002; 50: 29–32.
Hoff G, Bretthauer M, Huppertz-Hauss G, Kittang E, Stallemo A, Hoie O, et al. The Norwegian Gastronet project: Continuous quality improvement of colonoscopy in 14 Norwegian centres. Scand J Gastroenterol 2006; 41: 481–7.
Lambert R, Mahe C. Screening for digestive cancers: from theory to practice. World Gastroenterology News 2006; 11: 42–5.
Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003; 98: 2082–91.
Adams EK, Thorpe KE, Becker ER, Joski PJ, Flome J. Colorectal cancer screening, 1997–1999: role of income, insurance and policy. Prev Med 2004; 38: 551–7.
Ocvirk J. Nov pristop k zdravljenju raka. Rak debelega črevesa in danke – pogostnost v svetu in pri nas. Isis 2005; 6: 100–01.
Raza M, Bernstein CN, Ilnyckij A. Canadian physicians’ choices for their own colon cancer screening. Can J Gastroenterol 2006; 20: 281–4.
Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial. Eur J Cancer Prev 2006; 15: 10–19.
Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 2006; 98: 570–1.
Rossi PG, Federici A, Bartolozzi F, Farchi S, Borgias P, Guasticchi G. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial. BMC Public Health 2005; 5: 139–49.
Andreu-Vaillo Y, Galdon Garido MJ, Dura Ferrandis E, Carretero Gomez S, Tuelles Hernandez J. Age, health beliefs and attendan
ce to a mammography screening program in the community of Valencia. Rev Esp Salud Publica 2004; 78: 65–82.
Davila RE, Rajan E, Todd HB. ASGE guideline: colorectal cancer screening and surveillance. Standards of practice committee. Gastrointest Endosc 2005; 63: 546–57.
Winawer SJ. Zauber AG, Ho MN. Prevention of colorectal cancer by colonoscopic polypectomy: the National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977–81.
Citarda F, Tomasselli G, Capoccacia R. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812–5.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
